Ir para o conteúdo principal
McPherson's slashes earnings guidance as sales slump
Image for illustrative purposes only. Not a real photo.

McPherson's slashes earnings guidance as sales slump

Share

McPherson's (ASX:MCP) has downgraded its earnings guidance for the 2026 financial year, citing sluggish sales and rising supply chain costs.

In a trading update, the health and beauty supplier walked back its previous forecast of moderate growth, now stating it no longer expects a year-on-year increase in underlying EBITDA.

The company attributed the revised outlook to sales volumes falling short of internal targets as it continues to bed down a new operating model.

McPherson's noted that macroeconomic pressures have forced several suppliers to introduce surcharges to cover their own rising costs.

Despite the downgrade, management remains optimistic about a stronger second half and confirmed that the company’s share buyback programme will continue, supported by a robust balance sheet and a net cash position.

At the time of reporting, McPherson's share price was $0.15.

Perguntas frequentes